About: Medex

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Medex Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

company

Attributes	Values
rdf:type	Item
description	company (en) компанія (uk)
rdfs:label	Medex (en) Medex (fr)
skos:prefLabel	Medex (en) Medex (fr)
name	Medex (en) Medex (fr)
legal form	wds:Q55670688-57A7F2D1-4912-40E4-AF88-88026D59023C
legal form	société par actions simplifiée
instance of	wds:Q55670688-cb2afccc-4f87-2db2-cc73-53a7edc4c1d6
instance of	business
country	wds:Q55670688-ab5d3d40-481b-35ed-b995-cc79924af73c
country	France
inception	wds:Q55670688-9e6b1dd6-4f0d-1924-d748-3bd10301f601
inception	1988-01-01 00:00:00Z (xsd:dateTime)
headquarters location	wds:Q55670688-7295b84e-4cfb-a678-d4ac-1aa256d278c4
headquarters location	Saint-Priest
SIREN number	wds:Q55670688-11ab5942-440e-ecd2-aca3-9032ec315a44
SIREN number	340598978
skos:altLabel	Medex by Guerbet (en)
official website	wds:Q55670688-35c4bac5-4f04-03ea-6f9d-2cb9510fd717
official website	http://medexbyguerbet.com/
OpenCorporates ID	wds:Q55670688-4cb2cd99-454f-2e6d-a8b6-8d32b06714ff
industry	wds:Q55670688-0DB09E52-936C-4575-90AB-60A961F6EDC7
parent organization	wds:Q55670688-52529e73-469b-47f5-1a05-54b6edc9635d
OpenCorporates ID	fr/340598978
industry	wd:Q112165493
parent organization	Guerbet
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q55670688
is research site of	A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period o Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) The Plecanatide Chronic Idiopathic Constipation (CIC) Study Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication A Phase 3 Study of Tanezumab for Chronic Low Back Pain
is research site of	wds:Q63833535-78CF4F15-E01C-4A71-8A6E-35619751445C wds:Q61967058-BC28A6C3-32B6-45E2-8EAF-981C1668627E wds:Q63841350-66235808-162C-4813-9D0F-7C98882B178B wds:Q64607397-15BE59E1-D8C3-4F1D-91A9-EC7ED2D6718E wds:Q64610098-1116BB42-AC2D-489E-BE50-DE98BC1B15D7 wds:Q64640439-5632BBB6-E035-490F-A4EE-9723076C5BEC wds:Q100788927-70B639D6-A055-4195-AF7E-446D1E897EB9 wds:Q63336005-1CA08360-8005-47CB-AA05-CB0922522A4E wds:Q63340267-CBE67692-2914-4C07-A1EF-9D317B034F9A wds:Q61922098-0F0244F2-9612-4F87-AC26-7A05DC97F96F wds:Q63815908-5C6C0943-4A30-448D-A1D2-28BF7BED64B9 wds:Q65391547-13B094CD-86D9-469C-93FF-990BBA9A5A7E wds:Q65376259-4567956E-7E96-4024-BCD5-2949DC75870C wds:Q66035634-768F8D4A-4FC7-43CC-ADB0-C56623515CBB wds:Q61909227-30F7BF4B-CDB0-4483-863E-9795D890FE01 wds:Q61915405-0BC2C2CD-F8FC-45E5-8CE5-772D5E6F699D wds:Q61918199-6AD62446-0F72-48EA-A55B-5F8148AE8C6C wds:Q61970190-EC9FE652-482F-4022-842C-B04253E6174A wds:Q63807386-73A63A5C-C1E3-415B-9556-5DC0418FB089 wds:Q63403162-6AB58D37-33EF-40F1-8E0E-B8EC2F05EC37 wds:Q64648387-29472191-F64B-43BF-A4D0-5F6064525245 wds:Q62104945-677E7747-3BA0-4F85-BFD5-D691B1981158 wds:Q64724262-F5DF1B13-A776-41AB-A529-F568796BE373 wds:Q61862248-AFA37DB6-1165-4A9E-A8D2-9DC864BD9A45 wds:Q64658949-8569E058-ED68-403C-A204-BB6AA7BF895A wds:Q66035637-26243426-A8AE-4FC0-8D7A-D94BCBBF6E78 wds:Q64680914-996A7478-23EC-4E63-8ED4-CFA4FF7FE81B wds:Q64603715-43D5EC02-CD97-4083-B060-00883327E8FA wds:Q64651907-D3FAD5B5-81B1-4E9D-864C-A5A51C2C1CA8 wds:Q65336005-DA976057-A81A-4992-B690-96EA666A283A
is has subsidiary of	Guerbet
is sponsor of	Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
is has subsidiary of	wds:Q906156-7d8d8fe1-40d9-a76d-4fd0-47b530476680
is sponsor of	wds:Q65545410-6CB38258-DC9B-4A2B-B031-2700BFB6A6F3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software